Such reduction of PICALM seems related to the fact that PICALM is a substrate of both calpain and caspase-3 [33,79,80] that are activated in the brains of AD and other tauopathies [136,137,138,139,140]. The gene discussed is PICALM; the disease is Alzheimer disease.